A Pregnant Patient with ITP and an Acquired Bernard Soulier Syndrome Who Interfered with Treatment Plan

Abstract

Since incidence of gestational thrombocytopenia is 5% during pregnancy, gestational immune thrombocytopenic purpura (ITP) should be differentiated from gestational thrombocytopenia. In gestational ITP, corticosteroids, intravenous immunoglobulin (IVIG) therapy and splenectomy are reliable treatment options. We present a patient diagnosed as ITP on 13th gestational week given IVIG who refused to take IVIG during the course of therapy and interrupted treatment. During her treatment, she was convinced to receive IVIG for a period but then refused again to take this treatment later. Her treatment was continued with steroids. Laparosopic splenectomy was performed at postpartum period. Copyright © Hellenic Society of Haematology.